AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Colorectal Resections in Patients With Retroperitoneal Sarcoma

Recruitingn/aAges 18 Years - anyAllHeidelberg University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

COLOSARC-Q is a multicenter study with the objective of providing an up-to-date assessment of colorectal resections and reconstruction techniques in the context of multivisceral resections for retroperitoneal sarcomas, as well as colorectal surgery-associated complications and their impact on patients' quality of life. In multivisceral resections involving the colon and rectum, the primary aim is to achieve complete resection and preserve organ function. However, multivisceral resections have a high risk of perioperative morbidity including anastomotic leakage. The proposed project aims to determine the number of primary anastomoses, their insufficiency rates, and the fraction of patients with primary and secondary stomas. In addition, the patients' quality of life after multivisceral sarcoma resection is to be recorded using standardized surveys. The analysis has the potential to faci

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Histological confirmation with evidence of a retroperitoneal sarcoma * Tumor resection with colorectal resection * Surgery in a DKG-certified sarcoma center or hospital that meets certification-equivalent criteria * Age 18 years or older * Written consent Exclusion Criteria: * Absence of consent
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

16 sites
Sarcoma Center of University Medical Center Mannheim
Mannheim, Germany
University Medical Center Goettingen
Gรถttingen, Germany
Helios Hospital Berlin-Buch
Berlin, Germany
University Hospital Koeln
Cologne, Germany
University Medical Center Dresden
Dresden, Germany
University Medical Center Erlangen
Erlangen, Germany
University Medical Center Greifswald
Greifswald, Germany
University Medical Center Halle
Halle, Germany

โ€ฆand 8 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy